Claritas Pharmaceuticals, Inc. (CLAZF)

USD 0.0

(0.0%)

Annual Income Statements

(In USD)
Breakdown 2022 2021 2020 2019 2018 2017
Revenue - - - - - -
Cost of Revenue - - - - - -
Gross Profit - - - - - -
Operating Expenses - - -184 Thousand 9.45 Million 11.1 Million 4.91 Million
Selling, General and Administrative Expenses - - 1.87 Million 3.66 Million 3.35 Million 3.24 Million
Research and Development Expenses - - -2.05 Million 5.79 Million 7.75 Million 1.67 Million
Other Expenses - - - - -2.49 Million -9.91 Million
Cost and Expenses - - -184 Thousand 9.45 Million 11.1 Million 4.91 Million
Operating Income - - -3.27 Million -25.87 Million -4.58 Million -14.49 Million
Interest Expense - - 225 Thousand 209 Thousand 153 Thousand 16.03 Million
Income Tax Expense - - -4.88 Million -4.62 Million -99 Thousand -1.85 Million
Earnings before Tax - - -674 Thousand -25.83 Million 6.83 Million -31.86 Million
Net Income - - 4.21 Million -21.21 Million 6.93 Million -31.86 Million
Earnings Per Share Basic - - 0.17 -0.95 0.64 -5.13
Earnings Per Share Diluted - - 0.17 -0.95 0.64 -5.13
Weighted Average Shares Outstanding - - 26.69 Million 22.44 Million 10.91 Million 6.2 Million
Weighted Average Shares Outstanding (Diluted) - - 26.69 Million 22.44 Million 10.91 Million 6.2 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA - - -2.79 Million -9.49 Million 18.13 Million -15.44 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts